← Back to guidelines
Cardiology151 papers

Cardiac channelopathy

Last edited: 4/15/2026

Overview

Cardiac channelopathies involve mutations in genes encoding ion channels, leading to abnormal electrical activity in the heart. These conditions can cause arrhythmias, syncope, and sudden cardiac death due to impaired sodium ion extrusion and channel function 12.

Diagnosis

  • Genetic Testing: Identify mutations in genes like SCN5A (e.g., D1275N) 2.
  • Electrocardiogram (ECG): Reveals characteristic patterns such as prolonged QT intervals in LQTS 3.
  • Holter Monitoring: Useful for detecting intermittent arrhythmias 3.
  • Electrophysiology Studies: Confirm channel dysfunction and arrhythmia mechanisms 3.
  • Management

  • Beta-Blockers: First-line treatment for LQTS to reduce arrhythmic events 3.
  • Antiarrhythmic Drugs: Class IA (e.g., procainamide) or IC (e.g., flecainide) for specific arrhythmias 3.
  • Implantable Cardioverter Defibrillators (ICDs): For high-risk patients with recurrent arrhythmic events 3.
  • Lifestyle Modifications: Avoid triggers like intense exercise in certain genotypes 3.
  • Special Populations

  • Pediatrics: Revised guidelines recommend tailored sports restrictions based on genotype and symptoms 3.
  • Comorbidities: Management strategies may need adjustment in the presence of other cardiac conditions 3.
  • Key Recommendations

  • Genetic Counseling and Testing: Essential for diagnosis and family screening 2.
  • Tailored Sports Recommendations: Children with channelopathies should follow genotype-specific guidelines for physical activity 3 (Evidence: Moderate).
  • Beta-Blockers for LQTS: Recommended for primary prevention in asymptomatic patients with LQTS 3 (Evidence: Strong).
  • References

    1 Apell HJ. Subtle mutation, far-reaching effects. The Journal of general physiology 2017. link 2 Hayano M, Makiyama T, Kamakura T, Watanabe H, Sasaki K, Funakoshi S et al.. Development of a Patient-Derived Induced Pluripotent Stem Cell Model for the Investigation of SCN5A-D1275N-Related Cardiac Sodium Channelopathy. Circulation journal : official journal of the Japanese Circulation Society 2017. link 3 Lang CN, Steinfurt J, Odening KE. Avoiding sports-related sudden cardiac death in children with congenital channelopathy : Recommendations for sports activities. Herz 2017. link

    Original source

    1. [1]
      Subtle mutation, far-reaching effects.Apell HJ The Journal of general physiology (2017)
    2. [2]
      Development of a Patient-Derived Induced Pluripotent Stem Cell Model for the Investigation of SCN5A-D1275N-Related Cardiac Sodium Channelopathy.Hayano M, Makiyama T, Kamakura T, Watanabe H, Sasaki K, Funakoshi S et al. Circulation journal : official journal of the Japanese Circulation Society (2017)
    3. [3]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG